Growth Metrics

SS Innovations International (SSII) Cash from Financing Activities (2016 - 2026)

SS Innovations International recorded quarterly Cash from Financing Activities of $18.2 million in Q1 2026, up 1222.47% quarter-over-quarter from $1.4 million in Q4 2025, and down 18.95% year-over-year from $22.4 million in Q1 2025.

SS Innovations International's Cash from Financing Activities history runs 11 years deep, the most recent figure standing at $18.2 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 18.95% year-over-year to $18.2 million; the TTM figure through Mar 2026 stood at $21.9 million (down 24.91% YoY), while the FY2025 annual figure was $26.2 million, up 177.6% from the prior year.
  • Cash from Financing Activities came in at $18.2 million for Q1 2026 at SS Innovations International, up from $1.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $22.4 million in Q1 2025 to a low of -$702098.0 in Q2 2025.
  • A 5-year average of $5.4 million and a median of $2.7 million in 2024 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities soared 15516.71% in 2022 and plunged 126.45% in 2025, its largest moves.
  • SS Innovations International's Cash from Financing Activities stood at $3.1 million in 2022, then sank by 95.1% to $150563.0 in 2023, then surged by 2165.52% to $3.4 million in 2024, then sank by 59.74% to $1.4 million in 2025, then surged by 1222.47% to $18.2 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $18.2 million, $1.4 million, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 17.31 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -1.51 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -451.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -25.00 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 21.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -97.90 Mn
10 SS Innovations International 770.31 Mn 746.70 Mn 5.33 Mn 18.16 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 18.16 Mn
Mar 31, 2026 18.16 Mn
Dec 31, 2025 1.37 Mn
Dec 31, 2025 1.37 Mn
Sep 30, 2025 3.09 Mn
Sep 30, 2025 3.09 Mn
Jun 30, 2025 -702,098.00
Jun 30, 2025 -702,098.00
Mar 31, 2025 22.41 Mn
Mar 31, 2025 22.41 Mn
Dec 31, 2024 3.41 Mn
Dec 31, 2024 3.41 Mn
Sep 30, 2024 722,336.00
Sep 30, 2024 722,336.00
Jun 30, 2024 2.65 Mn
Jun 30, 2024 2.65 Mn
Mar 31, 2024 2.64 Mn
Mar 31, 2024 2.64 Mn
Dec 31, 2023 150,563.00
Dec 31, 2023 150,563.00
Sep 30, 2023 16.89 Mn
Sep 30, 2023 16.89 Mn
Jun 30, 2023 3.14 Mn
Jun 30, 2023 3.14 Mn
Mar 31, 2023 2.62 Mn
Mar 31, 2023 2.62 Mn
Dec 31, 2022 3.07 Mn
Dec 31, 2022 3.07 Mn
Sep 30, 2022 2.01 Mn
Sep 30, 2022 2.01 Mn
Dec 31, 2021 289,199.00
Dec 31, 2021 289,199.00
Sep 30, 2021 12,900.00
Sep 30, 2021 12,900.00
Jun 30, 2021 32,850.00
Jun 30, 2021 32,850.00
Mar 31, 2021 235,000.00
Mar 31, 2021 235,000.00
Dec 31, 2020 205,945.00
Dec 31, 2020 205,945.00
Sep 30, 2020 8,700.00
Sep 30, 2020 8,700.00
Jun 30, 2020 16,130.00
Jun 30, 2020 16,130.00
Mar 31, 2020 36,000.00
Mar 31, 2020 36,000.00
Dec 31, 2019 93,485.00
Dec 31, 2019 93,485.00
Sep 30, 2019 150,000.00
Sep 30, 2019 150,000.00
Jun 30, 2019 90,000.00
Jun 30, 2019 90,000.00
Mar 31, 2019 133,500.00
Mar 31, 2019 133,500.00
Dec 31, 2018 30,000.00
Dec 31, 2018 30,000.00
Dec 31, 2017 81,185.00
Dec 31, 2017 81,185.00
Sep 30, 2017 461,075.00
Sep 30, 2017 461,075.00
Jun 30, 2017 -6,377.00
Jun 30, 2017 -6,377.00
Mar 31, 2017 119,500.00
Mar 31, 2017 119,500.00
Dec 31, 2016 18,453.00
Dec 31, 2016 18,453.00
Sep 30, 2016 18,028.00
Sep 30, 2016 18,028.00